{"database": "lobbying", "table": "lobbying_activities", "rows": [[1412870, "4de1cb7a-248f-467a-8144-20469bf77001", "Q2", "HOSPIRA, INC.", 318711, "HOSPIRA INC", 2013, "second_quarter", "PHA", "H.R. 486 - relating to the compounding of drug products\nHouse Discussion Draft amending 503A of FFDCA with respect to pharmacy compounding\nS. 959  Compounding and Pedigree bill", "HOUSE OF REPRESENTATIVES,SENATE", null, 240000, 0, 0, "2013-07-18T13:19:23.217000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1412870"], "units": {}, "query_ms": 0.5324819358065724, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}